Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

Share Price is delayed by 15 minutes
Get Live Data
283.50    4.10 (1.47%)
Bid:
283.30
Ask:
283.60
Spread: 0.30 (0.106%)
Market Cap: £4.76b
KGF Live PriceLast checked at - London Stock Exchange

Intraday Kingfisher Share Chart

Share Repurchase Programme

3 Oct 2023 07:30

RNS Number : 4380O
Kingfisher PLC
03 October 2023
 

 

 

KINGFISHER PLC

Share repurchase programme - First Tranche

 

3 October 2023: Kingfisher plc (the "Company" or "Kingfisher") announces that it has instructed BNP Paribas Exane ("BNP Paribas Exane") in relation to an irrevocable non-discretionary programme to purchase its shares for cancellation, during the period which commences today and ends no later than 12 January 2024 (the "Tranche"). BNP Paribas Exane will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.

 

The maximum amount allocated to the Tranche (excluding expenses) will be no greater than £50 million (Note 1). The purpose of the Tranche is to reduce the share capital of the Company. As such, the Company will cancel any ordinary shares purchased. This is the first tranche of an overall commitment by the Company to purchase £300 million of its shares for cancellation, as announced on 19 September 2023 (the "Programme").

 

Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase shares, the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules. The Company confirms that it currently has no unpublished price sensitive information.

 

For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

 

BNP Paribas Exane (or any affiliate) may undertake transactions in Ordinary Shares (which may include sales, derivatives, and other hedging activities, in addition to purchases) in order to manage its risk positions arising directly or indirectly from the Programme. Disclosure of any such transactions will not be made by BNP Paribas Exane (or any affiliate) as a result of or as part of the Programme, but BNP Paribas Exane (or any affiliate) will make any disclosures they are legally required to make in relation to such transactions.

 

Note 1. The maximum number of shares that the Company may purchase would be 172,783,432 ordinary shares of 15 5/7 pence each, in line with the authority granted to Kingfisher by shareholders at the Company's Annual General Meeting on 27 June 2023 and taking into account the 21,143,586 shares purchased and cancelled during the fifth and final tranche of the previous £300 million share repurchase programme (announced on 7 July 2023).

 

 

Contacts

Tel:

Email:

Company Secretary

+44 (0) 77 6880 6248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 79 7767 8200

treasury@kingfisher.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMTBFTMTAMBJJ
Date   Source Headline
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20264:00 pmRNSHolding(s) in Company
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirectorate change
2nd Feb 202611:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:30 amRNSShare Repurchase Programme - Fifth Tranche
23rd Jan 20262:00 pmRNSBlock Listing Return
22nd Jan 20267:05 amRNSFourth Tranche of Share Repurchase Programme
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20264:30 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:30 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20264:00 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 202511:00 amRNSHolding(s) in Company
23rd Dec 202511:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.